We are live on
!
Find out more
Vir Biotechnology
61 hedge funds and large institutions have $1.3B invested in Vir Biotechnology in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
383% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 6
182% more capital invested
Capital invested by funds: $460M → $1.3B (+$838M)
104% more call options, than puts
Call options by funds: $699K | Put options by funds: $342K
61% more funds holding
Funds holding: 38 → 61 (+23)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
1.13% more ownership
Funds ownership: 33.36% → 34.49% (+1.1%)
Holders
61
Holders Change
+23
Holders Change %
+60.53%
% of All Funds
1.34%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
29
Increased
15
Reduced
10
Closed
6
Calls
$699K
Puts
$342K
Net Calls
+$357K
Net Calls Change
+$357K
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$7.27M |
| 2 |
BlackRock
New York
|
+$4.48M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$2.98M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.47M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.3M |
Top Sellers
| 1 |
ICP
Indus Capital Partners
New York
|
-$16M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$9.95M |
| 3 |
IC
Iconiq Capital
San Francisco,
California
|
-$6.72M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$941K |
| 5 |
Blackstone Inc
New York
|
-$440K |
